🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/09/2004 | 41,07 | 42,79 | 41,07 | 42,42 | +0,82% | 4,18% | 8.077.460 |
| 24/09/2004 | 42,22 | 42,34 | 42,02 | 42,08 | -0,38% | 0,75% | 5.092.861 |
| 23/09/2004 | 42,70 | 43,01 | 42,18 | 42,24 | -1,07% | 1,94% | 5.173.033 |
| 22/09/2004 | 42,56 | 42,83 | 42,46 | 42,70 | -0,20% | 0,87% | 5.685.190 |
| 21/09/2004 | 42,63 | 43,02 | 42,54 | 42,79 | +0,38% | 1,14% | 5.749.538 |
| 20/09/2004 | 42,80 | 42,97 | 42,38 | 42,62 | -0,67% | 1,38% | 7.222.187 |
| 17/09/2004 | 43,32 | 43,34 | 42,89 | 42,91 | -0,46% | 1,04% | 7.278.150 |
| 16/09/2004 | 43,32 | 43,42 | 42,97 | 43,11 | -0,48% | 1,04% | 3.930.943 |
| 15/09/2004 | 43,64 | 43,70 | 43,13 | 43,32 | -0,33% | 1,31% | 5.555.762 |
| 14/09/2004 | 43,37 | 43,77 | 43,05 | 43,46 | +0,22% | 1,65% | 5.633.838 |
| 13/09/2004 | 43,41 | 43,42 | 42,99 | 43,37 | -0,70% | 0,99% | 8.444.574 |
| 10/09/2004 | 42,95 | 43,86 | 42,94 | 43,67 | +1,13% | 2,13% | 5.194.831 |
| 09/09/2004 | 43,55 | 43,55 | 43,10 | 43,19 | -0,83% | 1,03% | 4.854.546 |
| 08/09/2004 | 43,56 | 43,88 | 43,48 | 43,55 | -0,31% | 0,92% | 5.784.331 |
| 07/09/2004 | 43,56 | 43,82 | 43,27 | 43,68 | +0,66% | 1,25% | 5.260.646 |
| 03/09/2004 | 43,21 | 43,61 | 43,15 | 43,40 | +0,86% | 1,06% | 4.767.457 |
| 02/09/2004 | 42,61 | 43,23 | 42,37 | 43,02 | +1,23% | 2,04% | 4.607.008 |
| 01/09/2004 | 42,55 | 42,64 | 42,10 | 42,50 | -0,96% | 1,28% | 5.221.555 |
| 31/08/2004 | 42,84 | 43,15 | 42,47 | 42,91 | +0,09% | 1,58% | 5.777.414 |
| 30/08/2004 | 42,80 | 43,59 | 42,80 | 42,87 | -0,49% | 1,85% | 5.036.898 |
| 27/08/2004 | 42,99 | 43,21 | 42,92 | 43,08 | +0,22% | 0,67% | 5.897.201 |
| 26/08/2004 | 43,37 | 43,42 | 42,66 | 42,99 | -2,11% | 1,74% | 9.650.298 |
| 25/08/2004 | 44,23 | 44,70 | 43,22 | 43,91 | -0,71% | 3,37% | 7.762.746 |
| 24/08/2004 | 44,29 | 44,52 | 44,06 | 44,23 | +0,28% | 1,03% | 3.711.073 |
| 23/08/2004 | 44,80 | 44,85 | 44,06 | 44,10 | +0,30% | 1,77% | 3.886.822 |
| 20/08/2004 | 43,21 | 44,30 | 43,21 | 43,97 | +1,45% | 2,54% | 5.898.982 |
| 19/08/2004 | 43,47 | 43,66 | 43,04 | 43,34 | -0,85% | 1,43% | 3.925.494 |
| 18/08/2004 | 42,61 | 43,71 | 42,61 | 43,71 | +1,87% | 2,60% | 5.520.654 |
| 17/08/2004 | 42,94 | 42,99 | 42,63 | 42,91 | -0,22% | 0,82% | 5.392.694 |
| 16/08/2004 | 42,37 | 43,08 | 42,37 | 43,01 | +1,08% | 1,69% | 3.747.543 |